If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1005
Bid: 0.10
Ask: 0.1045
Change: 0.00 (0.00%)
Spread: 0.0045 (4.50%)
Open: 0.1005
High: 0.00
Low: 0.00
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

General Meeting Statement

30 Oct 2023 07:00

RNS Number : 6221R
Versarien PLC
30 October 2023
 

 

 

30 October 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

General Meeting Statement

 

Versarien plc (AIM: VRS), the advanced materials engineering group, will be holding a General Meeting at 10.00 a.m. today, at which the following statement will be provided:

 

"Versarien's turnaround continues to progress in line with its stated strategy and we are pleased to provide a further update on progress following the Company's most recent corporate update on 2 October 2023.

 

The mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020 continue to be marketed for sale and we have a number of interested parties that we are progressing discussions with. The sale process for AAC Cyroma Limited, a manufacturer of moulded products, is the most advanced. However, the timing of any asset sales and the total quantum of the funds that may be received remains uncertain.

 

Further commercial progress continues to be made in the Company's core areas of leisure and construction. In the leisure area, discussions have been held with a number of potential new customers for the Company's Graphene-Wear? coatings in recent weeks.

 

In construction, in addition to a number of ongoing Cementene? trials, the Company is engaged in the production of additional 3D printed concrete structures and Versarien's participation in the Digital Roads of the Future and Roads Research Alliance programmes is generating further potential opportunities, including the potential use of graphene in asphalt resurfacing.

 

The Company continues to focus on obtaining and executing funded research and development projects. As referenced in the Company's Corporate Update announcement on 2 October 2023, Gnanomat S.L. is undertaking a nine-month project, at an undisclosed value, with CBMM Technology Suisse SA (part of Brazilian mining giant CBMM), to develop novel supercapacitors and 2-DTech Limited has a £44,200 contract, over approximately 14 weeks, with a UK aviation company to assess graphene / thermoset composites. Versarien Graphene Limited was also recently awarded a £48,600 contract by the Office of Product Safety and Standards, part of the UK Department for Business and Trade, for a five-month project to assess the physical and mechanical properties of 3D printed concrete.

 

In the UK, the Company has supported funding applications for a number of newly proposed EPSRC (Engineering and Physical Sciences Research Council) Centres for Doctoral Training (CDT) and key UK research hubs relevant to Versarien's core business. Following the end of the Graphene Flagship Core 3 project, Versarien has submitted an EIC Transition grant application, together with other academic and industry partners. The Company is also involved in discussions regarding future European Commission proposals for one of the new candidate European Partnerships, 'Innovative Materials for EU', and has pledged support for new consortia such as 2D-MIC (2D Materials Industry & Innovation Consortium). The UK's re-entry into Horizon Europe from January 2024 will be crucial for our participation in such initiatives.

 

We are pleased with the increasing level of commercial engagement in both of the Company's core areas of leisure and construction. The Company's strategy, which is focused on a light manufacturing model, is progressing as planned and we look forward to updating shareholders on further progress in due course."

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
GMSPPGPWUUPWGRB
Date   Source Headline
7th Jun 20182:00 pmRNSPrice Monitoring Extension
7th Jun 20187:00 amRNSVersarien appointed to NGA Industry Council
29th May 20187:00 amRNSConsumer Goods Collaboration
22nd May 20187:00 amRNSAppointment of senior DIT secondee
4th May 20187:00 amRNSChange of Nominated Adviser and Broker
30th Apr 20187:00 amRNSAgreement with Luxus
16th Apr 20187:25 amRNSGraphene Supply to Major Tyre Producer
3rd Apr 20181:32 pmRNSHolding(s) in Company
28th Mar 20187:00 amRNSHexotene Product Launch
27th Mar 20187:00 amRNSCollaboration with World Leading Aerospace Group
14th Mar 20187:00 amRNSCollaboration with Team Sky
7th Mar 20181:15 pmRNSAdditional Investor Event
7th Mar 20187:00 amRNSInvestor Event
27th Feb 20184:41 pmRNSSecond Price Monitoring Extn
27th Feb 20184:35 pmRNSPrice Monitoring Extension
27th Feb 20187:00 amRNSAgreement with Vivobarefoot
21st Feb 20187:00 amRNSMedical Technology Collaboration
5th Feb 20187:00 amRNSAppointment to US National Graphene Advisory Board
2nd Feb 20184:40 pmRNSHolding(s) in Company
29th Jan 20183:18 pmRNSExercise of Options
23rd Jan 20183:33 pmRNSHolding(s) in Company
15th Jan 20182:05 pmRNSSecond Price Monitoring Extn
15th Jan 20182:00 pmRNSPrice Monitoring Extension
15th Jan 201811:05 amRNSSecond Price Monitoring Extn
15th Jan 201811:00 amRNSPrice Monitoring Extension
15th Jan 20189:05 amRNSSecond Price Monitoring Extn
15th Jan 20189:00 amRNSPrice Monitoring Extension
15th Jan 20187:00 amRNSPlanned Chinese graphene manufacturing facility
8th Jan 20187:00 amRNSAgreement with Global Apparel Manufacturer
5th Jan 201811:05 amRNSDirector/PDMR Shareholding
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSExercise of Options
4th Dec 201711:05 amRNSSecond Price Monitoring Extn
4th Dec 201711:00 amRNSPrice Monitoring Extension
4th Dec 20179:00 amRNSPrice Monitoring Extension
4th Dec 20177:00 amRNSAgreement with Global Chemical Major
1st Dec 20172:05 pmRNSSecond Price Monitoring Extn
1st Dec 20172:00 pmRNSPrice Monitoring Extension
29th Nov 20177:00 amRNSInterim Results
28th Nov 20172:05 pmRNSSecond Price Monitoring Extn
28th Nov 20172:00 pmRNSPrice Monitoring Extension
21st Nov 20179:05 amRNSSecond Price Monitoring Extn
21st Nov 20179:00 amRNSPrice Monitoring Extension
17th Nov 20177:00 amRNSCollaboration with Global Consumer Goods Company
7th Nov 20174:40 pmRNSSecond Price Monitoring Extn
7th Nov 20174:35 pmRNSPrice Monitoring Extension
7th Nov 20173:07 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSSuccessful Fundraising of £2.9 million
3rd Nov 20174:43 pmRNSFundraising of approximately £1.2 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.